During their evolution, animals have developed a set of cysteine-rich peptides capable of binding various extracellular sites of voltage-gated sodium channels (VGSC). Sea anemone toxins that target VGSCs delay their inactivation process, but little is known about their selectivities. Here we report the investigation of three native type 1 toxins (CGTX-II, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b) purified from the venom of Bunodosoma cangicum. Both ␦-AITX-Bcg1a and ␦-AITX-Bcg1b toxins were fully sequenced. The three peptides were evaluated by patch-clamp technique among Nav1.1-1.7 isoforms expressed in mammalian cell lines, and their preferential targets are Na v 1.5 > 1.6 > 1.1. We also evaluated the role of some supposedly critical residues in the toxins which would interact with the channels, and observed that some substitutions are not critical as expected. In addition, CGTX-II and ␦-AITX-Bcg1a evoke different shifts in activation/inactivation Boltzmann curves in Nav1.1 and 1.6. Moreover, our results suggest that the interaction region between toxins and VGSCs is not restricted to the supposed site 3 (S3-S4 linker of domain IV), and this may be a consequence of distinct surface of contact of each peptide vs. targeted channel. Our data suggest that the contact surfaces of each peptide may be related to their surface charges, as CGTX-II is more positive than ␦-AITX-Bcg1a and ␦-AITX-Bcg1b.
Introduction
Voltage-gated sodium channels (VGSCs) represent the excitability face of the nervous, muscular and cardiac systems because they participate in the generation and propagation of action potentials. They are composed of a pore-forming ␣-subunit associated with up to four known different ␤-subunits. The tetrodotoxin (TTX)-sensitive Na + channels are classified according to sequence homology as Na v 1.1 to Na v 1.7 and they are differentially distributed in the central and peripheral nervous system, in skeletal muscle, and in cardiac muscle. VGSC and K + channels dysfunction (channelopathies) can result in neuromuscular diseases and heart or brain disorders such as arrhythmias and epilepsy [1, 14, 18] .
Abbreviations: CGTX-II, cangitoxin-II; VGSC, voltage-gated sodium channels.
Mutations in the genes encoding for Na v 1.1 and Na v 1.2 isoforms have been linked to various forms of epilepsy and febrile seizures [21] . Thus, the key role of VGSCs in many tissues makes them important targets for pharmacological and biophysical studies, especially by dissecting the specific toxin-channel interactions.
The investigation on the pharmacology of sodium channel toxins from sea anemones started more than 30 years ago [4, 26] , and further studies on site-directed mutagenesis took place later in the 1990s [11, 15, 16, 25] . Nevertheless, very few information on electrophysiological and selectivity effects in a broader range of channels was reported [6, 23] .
Sea anemone type 1 toxins are peptides whose binding sites in VGSCs partially overlap with those of ␣-scorpion toxins. Their actions involve almost completely and selectively to induce a particular delay in ion channel conformational change called inactivation (transition from the open to the shut state) as opposed to the early process of activation (opening of the Na + -selective pore). This inactivated state is distinct from the closed state and there are many different methods to manipulate it from the intracellular side, either by using enzymes [2] , drugs, point mutations (for a review see Ulbricht [33] ) and specific toxins from venomous animals.
In the present paper, we studied three sea anemone type 1 toxins (CGTX-II, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b) purified from the venom of the sea anemone Bunodosoma cangicum. Two of those toxins (␦-AITX-Bcg1a and ␦-AITX-Bcg1b) differ in only one amino acid (N 16 D), but their potencies are markedly different. Also, in contrast to CGTX-II, both ␦-AITX-Bcg1a and ␦-AITX-Bcg1b have substitutions at positions 36-38. These positions were reported, in other sea anemone toxins, to be involved in the toxin-channel interaction, then inducing a robust increase in the slow component of the inactivation [5, 25, 28, 31] , which is the origin of the physiological prolongation of the action potential.
In this work we also aimed to investigate all the biophysical properties crucially involved in the action produced by these toxins on the inactivation process of the sodium current, especially taking into account that the selectivity of these types of peptides among the subtypes of VGSCs is poorly known. Also, we evaluated by molecular modeling the charge distribution among the three different toxins, which may be implied in their different potencies and selectivities. We should also mention that in order to standardize the as yet confusing nomenclature of animal toxins, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b were named following a nomenclature rationale recently proposed [17] .
Materials and methods

Toxins purification
Venom collection, fractionation and purification of toxins
Forty B. cangicum specimens were collected on the northern coast of São Paulo State, Brazil, and the venom was obtained by electrical stimulation of animals as previously described [20] . The B. cangicum venom (approximately 150 mg) was fractionated by gel filtration chromatography using a Sephadex G-50 column (1.9 cm × 131 cm, GE Healthcare, Uppsala, Sweden), as described [19, 23] . Pools of the neurotoxic fraction, eluted in the third peak (Fr III), were submitted to RP-HPLC chromatography in an ÄKTA Purifier machine (GE Healthcare, Uppsala, Sweden) using a semipreparative CAPCELL PAK C-18, 10 mm × 250 mm (Shiseido Corp., Kyoto, Japan) column. Approximately 10 mg of the neurotoxic pool were fractionated (1 mg per run) by RP-HPLC. The HPLC conditions used were: 0.1% trifluoroacetic acid (TFA) in water (solvent A) and acetonitrile containing 0.1% TFA (solvent B). The separations were performed at a flow rate of 2.5 mL/min and a 10-60% gradient of solvent B over 40 min. The eluted peptides were monitored at UV 214 nm, as described [36] . The peaks eluted at 30.24 and 30.57 min, respectively, were manually collected and lyophilized or concentrated for further re-purifications [36] . Each of these components were re-purified twice by employing isocratic condition at 29% of solvent B, in order to best fit the purified peptides to proper peak symmetry. After obtaining good peak symmetries suggesting high purity, molecular mass assessments by MALDI-Tof mass spectrometry were carried out. The peptide cangitoxin-II (CGTX-II) was purified as previously reported [35] . The protein contents of both the neurotoxic fraction and the pure peptide samples were estimated by the bicinchoninic acid (BCA) method (Pierce, Rockford, USA) following the manufacturer's instructions.
Mass spectrometry analyses
Analyses of pure peptides obtained in the previous step were performed on an Ettan MALDI-TOF/Pro (GE Healthcare, Uppsala, Sweden) equipped with 337 nm pulsed nitrogen laser under reflectron mode. The accelerating voltage was 20 kV. Matrix, ␣-cyano-4-hydroxycinnamic acid (Sigma-Aldrich Co., USA), was prepared at a concentration of 10 mg/mL in 1:1 CH 3 CN/0.1% TFA.
External calibration was performed with [Ile 7 ]-angiotensin III (m/z 897.51, monoisotopic, Sigma) and insulin (m/z 5734.49, average, Sigma). The sample solution (0.5 L) dropped onto the MALDI sample plate was added to the matrix solution (0.5 L) and allowed to dry at room temperature.
Determination of amino acid sequences
The N-terminal amino acid sequences of the native peptides were determined by automated Edman degradation using a Shimadzu PPSQ-21A protein sequencer. To obtain their complete sequences, the peptides were reduced and S-alkylated with vinyl pyridine according to the method described by Henschen [13] . Each sample was dissolved in 1 mL of 6 M guanidine-HCl in 0.1 M tris-HCl, pH 8.6 . To this solution 30 L of 2-mercaptoethanol was added under nitrogen and the sample incubated at 50 • C for 4 h. After this, 40 L of 4-vinylpyridine was added and the samples were incubated under nitrogen at 37 • C in the dark during 2 h. The samples were then desalted on a Vydac C4 column, using a gradient of 0-65% acetonitrile in 0.1% TFA during 140 min and lyophilized. The S-pyridyl-ethylated peptides were dissolved in 200 L of 8 M urea, and then diluted with 1.8 mL of 0.1 M ammonium bicarbonate (pH 7.9) and digested at 37 • C with chymotrypsin (2%, w/w enzyme/substrate) for 3 h. The peptides produced by this digestion were separated by reverse phase HPLC on a Vydac C-18 column (4.6 mm × 250 mm, i.d.) (small pore) using an extended gradient of 0-50% acetonitrile in 0.1% trifluoroacetic acid for 180 min at a flow rate of 1 mL/min. Centre, Gunnels Wood Rd., Stevenage, Herts SG1 2NY, UK) were cultured in modified Dulbecco's medium supplemented with 10% fetal bovine serum as described [23] . Na V 1.4-expressing cells were obtained by stably transfecting a plasmid containing the hNa v 1.4 construct (a kind gift from Prof. Diana Conti-Camerino, University of Bari, Italy). Na V 1.7-expressing cells were obtained by transient transfection of a plasmid containing the hNa V 1.7 construct (a kind gift from Prof. Franz Hofmann through Prof. Akihiko Wada, University of Miyazaki, Japan). Approximately 2 × 10 4 cells were transfected with 2 g of hNa V 1.7 vector along with 0.2 g of green fluorescent protein (GFP) in pEGFP-C1 (Clontech, USA) using lipofectamine reagent kit (Invitrogen, USA) following the instructions of the manufacturer. Currents were recorded 24-72 h following transfection.
Electrophysiology in
Solutions and drugs
The standard extracellular solution contained (mM): NaCl 70, N-Methyl-d-Glucamine 67, CaCl 2 1, MgCl 2 1.5, HEPES 5, d-glucose 10 at pH 7.40. The standard pipette solution contained (mM): CsF 105, CsCl 27, NaCl 5, MgCl 2 2, EGTA 10, Hepes 10 at pH 7.30. About 6-8% of the cells in the clone expressing Na V 1.6 channels had a persistent Na + current, as reported by Burbidge et al. [7] . We systematically tested these cells and discarded those showing incomplete inactivation (a residual current after 250 ms of <0.1% of the peak Na + current). Known quantities of the toxins were dissolved in the extracellular solution immediately before the experiments. Tetrodotoxin (TTX, Sigma, Italy) was used at 300 nM on the Na V 1.1, 1.2, 1.3, 1.4, 1.6 and Na V 1.7 currents and the resulting traces were subtracted from the control traces to obtain the TTXsensitive currents; the Na V 1.5 clone (which has a TTX ID 50 much higher than 100 nM) never showed any significant contaminating potassium currents at the test potentials. The extracellular solutions were delivered through a remote-controlled 9-hole (0.6 mm) linear positioner placed near the cell under study. Average response time was 2-3 s.
Patch-clamp recordings and data analysis
The currents were recorded at room temperature using the MultiClamp 700A amplifier (Axon Instruments, USA) as previously described [23] ; pipette resistance was about 1.3-2.1 M . The cell capacitance and series resistance errors were carefully (85-90%) compensated before each run of the voltage clamp protocol in order to reduce voltage errors to less than 5% of the protocol pulse. The P/N leak procedure was routinely used. pClamp 8.2 (Axon Instruments, U.S.A.) and Origin 7 (Microcal Inc, USA) softwares were used during data acquisition and analysis. All data regarding activation were obtained using a holding potential of −90 mV, a 100 ms preconditioning of −120 mV (to completely remove fast inactivation) and a 7 ms test pulse from −80 to +40 mV. For steady-state inactivation (but, intentionally excluding the slow inactivation), the 200 ms preconditioning was variable from −120 to +10 mV and the test pulse was to −20 or −10 mV. To obtain the conductance-voltage data, the peak currents were divided by the driving force (V M + 67) and normalized using peak conductance values in the range +10/+30.
Data analysis, fitting procedures and qualitative screening at high (1.9 M) and low concentrations (50 nM)
As a general rule, we followed the procedures previously described [23, 30] . This procedure was based on the assumption that each Na + current trace is the sum of two exponential decaying components, which are the slow (s) and the fast (f) component (see the representative inset to Fig. 1 ), and eventually a steady-state (ss) component. We used as parameter for these components, their amplitude (as calculated by the Clampfit program (Axon Instruments, USA). Under control conditions, the amplitude of the fast component (A f ) was generally large and the amplitudes of the slow (A s ) and steady-state (A ss ) components were very low or negligible. During toxin action, a large increase in the A s occurred depending on the isoform (and was occasionally associated with an increase in A ss ). This strongly suggests that the currents recorded in the presence of toxin were always the sum of two types of currents: those deriving from toxinbound channels (modified) and those deriving from toxin-free channels (not modified and thus equivalent to control channels) [23, 30] .
Preliminary procedures used in Fig. 1 . We examined about 80 ms of each trace in control and computed A f and its time constant ( f ). In the presence of the toxin, we retained f of control and computed: (1) the amplitude of the fast-inactivating component originating from the unbound channels, namely A f , and (2) the A s component, originating from the toxin-bound channels (see representative inset to Fig. 1 ) [30] .
Procedures used in Figs. 2-4. This type of analysis is slightly different from the analysis reported in Oliveira et al. [23] because the voltage-dependent steady-state inactivation data were obtained as the ratio of the peak currents (A f + A s + A ss ) obtained at the preconditioning voltages (from −110 to +10 mV) and the maximal value obtained at −110 mV. From −110 to +10 mV we observed the normal decrease of the A f and A s components, but also the increase of the A ss component as shown in the inset to Fig. 2 upper-right (see under Na v 1.1 panel). The steady-state inactivation resulted to have a sigmoidal voltage-dependent curve, which, differently from control curves, was characterized by a non complete inactivation and a pedestal at depolarized potentials. This Voltage-dependent activation/inactivation for Nav1.5, Nav1.6 and Nav1.1 isoforms and recordings from representative cells. Columns and rows correspond to indicated isoforms and toxins, respectively. In each plot the steady-state inactivation (squares) and the activation (circles) are plotted; data with closed or open symbols correspond to control and toxin (CGTX-II, 5 and ␦-AITX-Bcg1a, 1.9 M), respectively. For each isoform and each toxin concentration not less than 5 cells were used. Lines are best-fitted Boltzmann curves whose values in control and in toxin, and statistical significance are shown in Table 2 . Insets show superimposed traces obtained in a representative cell in control and at two different toxin concentrations (CGTX-II, 1.9 and 5 M; ␦-AITX-Bcg1a, 0.5 and 1.9 M). The inset in the upper-right panel relative to isoform Nav1.1 shows, for a representative cell, the recordings of the inactivation protocol preconditioned at −80, −35 and +10 mV with the relative tests at −20 mV. This illustrates the increase of the Ass component both during preconditioning and test potentials and explains the pedestal at ∼0.2 in the inactivation curve at less negative potentials. last A ss effect indirectly and strongly affected the window current (normally negligible in control), thus producing a small and not always significant left-shift of the activation curves. When necessary the dose-response relationships of A s and A ss components were computed in Fig. 4. 
Molecular modeling and visualization
In order to visualize the 3D structure of each studied toxin, models of CGTX-II, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b were constructed using the SWISS-MODEL structure homology-modeling server (http://swissmodel.expasy.org/workspace/) [3] . The tridimensional structure of Anthopleurin-A toxin (determined by NMR) [24] (PDB ID: 1ahl) was employed as a template for all models. The structures were drawn and visualized by DeepView/PDB viewer [12] (http://www.expasy.org/spdbv, version 4.0.1) and PyMOL (The PyMOL Molecular Graphics System, Version 1.2, Schrödinger, LLC., http://www.pymol.org), and were rendered by PovRay (version 3.6 by Persistence of Vision Raytracer, Pty., Ltd.). All the three models were validated by the tools Anolea, DFire, QMEAN, Gromos, Promotif and ProCheck, available in the "structure assessment" tool of the SWISS-MODEL structure homology-modeling server.
Results
Isolation of toxins and determination of primary sequences
The toxins employed in this study were obtained according to the previously described procedures [35, 36] . Considering an urgent need for standardization of nomenclature of animal toxins, especially in sea anemones, we employed a rationale recently suggested [17] for the novel components eluted during RP-HPLC at 30.24 and 30.57 min from the neurotoxic fraction of B. cangicum venom. These peptides were named as ␦-Actitoxin-Bcg1a (␦-AITXBcg1a) and ␦-Actitoxin-Bcg1b (␦-AITX-Bcg1b), respectively. This rationale follows the biological effects exerted by the toxin (␦ letter for toxins that delay the inactivation process of ion channels) and the family of the organism which the toxin is derived ("Actitoxin" for toxins isolated from sea anemones of the "Actiniidae" family). Also, full sequences of each peptide were determined in this work. Both sequences were deposited at Uniprot server (http://www.ebi.ac.uk/uniprot/) and their accession numbers were assigned as P86459 and P86460, respectively. As CGTX-II (Uniprot ID: P0C7P9) had already been published [35] , we have not changed its name.
Initially, approximately 50 g of each native peptide was sequenced by the automated Edman degradation technique, and both peptides were directly sequenced up to the 39th residue. Considering that the peptides were not entirely sequenced, a protocol for reduction and alkylation, followed by digestion, was employed. To achieve this, the reduced and S-alkylated peptides were digested with chymotrypsin and the resulting products were separated into four (␦-AITX-Bcg1a) and three (␦-AITX-Bcg1b) peaks by RP-HPLC. However, there were two peptides purified from the digestion products of ␦-AITX-Bcg1a, showing the Asn and Asp amino acids at position 16. On the other hand, during sequencing of the native peptide, only the N 16 amino acid was observed. Thus, we assume that the amino acid D might have been produced either as a conversion of N to D during the S-pyridyl-ethylation or during digestion of the sample, and that it does not reflect the occurrence of both residues in the native materials employed in the electrophysiology assays. Also, the molecular mass determinations of ␦-AITX-Bcg1a present only the signal representing the N 16 Table 1 .
Qualitative screening at high and low concentrations
During the evaluation of the toxins we performed experiments both at high and saturating concentrations (see below in Fig. 4 ) and, at much lower concentrations, in those cases in which it was evident that the effects were interesting and pronounced. The experiments (see Methods Section 2.2.4) were designed to reduce the time-consuming electrophysiological protocols which indirectly let us to diminish the amount of toxin used in each test.
The results of these preliminary experiments are summarized in Fig. 1 where the ratio A s /(A s + A f ), here called fractional amplitude of the slow component of the current inactivation is plotted both vs. each channel isoform and each peptide. It can be seen that at saturating concentrations of 1.9 M, toxin ␦-AITX-Bcg1b was practically without effects in all the isoforms. On the contrary, the other two peptides (␦-AITX-Bcg1a and CGTX-II) were found to produce robust effects in all the isoforms except Na v 1.7. These peptides were also tested at a much lower concentration, where we were able to observe a very selective property for only one (␦-AITX-Bcg1a on Na v 1.5) or two isoforms (CGTX-II on Na v 1.5 and Na v 1.6).
Toxins selectivity on Na v 1.x isoforms
Since no effects were seen on the Na v 1.7 isoform and the toxin ␦-AITX-Bcg1b had little effect in any of the seven isoforms tested, we restricted our detailed analysis only to the first six isoforms as outlined below in Figs. 2-4 .
In Fig. 2 (for VGSC isoforms Na v 1.5, Na v 1.6 and Na v 1.1) and Fig. 3 (for Na v 1.4, Na v 1.2 and Na v 1.3) the voltage-dependent data (symbols) are shown in six plots each, where the two rows and Fig. 4 . Vulnerability of each Nav1.x isoform against different types of sea anemone toxins. Each graph describes the dose response curves of the fractional increase of As. Insets to Nav1.5, Nav1.6 and Nav1.1 isoforms plots show the fractional increase of the Ass (note the different y-scales as compared panels; the x-scale is in nM). CGTX-II and ␦-AITX-Bcg1a toxins data are shown as Hill curves (continuous lines, n = 5 for each isoform) best fitting experimental points (closed and open squares, respectively). The noncontinuous lines are the theoretical curves obtained by using ATX-II (dash line), AFT-II (dash-dot line) and BcIII (dots line) [23] . The Hill curve data for the following isoforms and for CGTX-II and ␦-AITX-Bcg1a (in parenthesis) had the following values: EC50 and slope 103 ± 8 nM, slope 1.8 ± 0.2 (440 ± 32, slope 1.2 ± 0.1) for Nav1.5, 133 ± 12 nM, slope 0.9 ± 0.06 (1740 ± 351, slope 0.85 ± 0.16) for Nav1.6 and 165 ± 6, slope 2.05 ± 0.2 (453 ± 31, slope 1.36 ± 0.15) for Nav1.1. three columns show results for the toxin types (CGTX-II at 5 M, ␦-AITX-Bcg1a at 1.9 M) and channel isoforms, respectively. All the quantitative data are shown in Table 2 where the typical biophysical properties are reported together with the statistical significance of the differences observed for the action of the two toxins.
As illustrated in Fig. 2 upper panels, CGTX-II affects isoform Na v 1.5 differently from isoforms Na v 1.6 and Na v 1.1. In Na v 1.5 the effect consists in a right-shift of inactivation; on the contrary in both Na v 1.6 and Na v 1.1 the effect consists in an incomplete inactivation from −40 up to +10 mV. The latter effect is due to a strong noninactivating A ss component that increased in a voltage-dependent Table 1 Primary sequence alignment of some Type 1 sea anemone toxins. Below are depicted toxins that have been subjected to extensive electrophysiological characterization (except cangitoxin). The peptides employed in this work have gray background names and are obtained from the species Bunodosoma cangicum [36] . Black, white and gray colors backgrounds mean identical, different and similar amino acids, respectively.
O denotes hydroxyproline amino acid in CgNa. Note the N 16 D substitution in ı-AITX-Bcg1a to ı-AITX-Bcg1b and cangitoxin-II, as well as in BgII and BgIII peptides. Also, it is interesting the occurrence of the negatively charged amino acid D 37 in ı-AITX-Bcg1a and ı-AITX-Bcg1b, as well as the D 36 and E 37 in CgNa peptide. For more details on the importance of these residues, refer to Section 4.
Table 2
Parameters from best fits to Boltzmann equations in Figs. 2 and 3 and statistical significance. Control data are derived by fitting procedure as explained in Methods (see Section 2.2.4). A two-sample paired t-test was done on the theoretical curves (15 points) best-fitting the experimental curves (in control and toxins) and one * or two ** denoted the statistical significance at levels of 0.05 or 0.001, respectively. Concentrations of CGTX-II and ␦-AITX Bcg1a were 5 and 1.9 M, respectively. Fig. 2 (upper-right panel) during the toxin action. The three superimposed traces elicited from −80, −35 and +10 mV, and immediately tested at −20 mV, show how the toxin exerts its effect by re-shaping the control steady-state inactivation and, at the same time, producing a small left-shift of the activation that resulted significant only for some isoform (see Table 2 ). This type of action is able to strongly modify the so called "window current" that is know to be able to alter the neuronal resting potential [9, 33] . Besides isoform Na v 1.5, also isoforms 1.4, 1.2 and 1.3 (shown in Fig. 3 ) are much less affected by the 2 toxins and did show only marginal and sometimes not significant effects. We noticed also small, but significant (p < 0.05) effects of left-shifts of the voltagedependent activation curves. CGTX-II produced very significant effects (p < 0.01) on inactivation in all isoforms except Na v 1.2 and Na v 1.4.
On the whole, these results suggest that the two different toxins were able to produce also different types of effects. Namely, it is possible to notice that CGTX-II was a toxin able to produce, only on the Na v 1.5 isoform, a right-shift of the inactivation curve, whereas all the other effects consisted in a more or less non complete inactivation process.
The dose-dependent action of the peptides and the VGSC isoforms vulnerability to different sea anemone toxins
Our present data and those previously described [23] for other sea anemone toxins, namely ATX-II, AFT-II and BcIII, constitute a set of results obtained with native peptides and could thus be useful to be compared. In order to do so, we plotted the fractional slow component (A s /(A s + A f )) increase vs. toxin concentration for the six most affected isoforms, and in Fig. 4 a comprehensive dose-response summary is shown where also the data reported in Oliveira et al. [23] have been superimposed.
As illustrated by the legends, CGTX-II (closed squares) and ␦-AITX-Bcg1a (open squares) data are plotted both as data points and best fitted Hill curves (see legend for the EC 50 and Hill coefficients).
It appears that three isoforms, namely Na v 1.5, Na v 1.6 and Na v 1.1, show EC 50 s in the region 80-150 nM. For the other isoforms we estimated EC 50 values of ∼5 M CGTX-II for Na v 1.4, and values >15 M for both toxins in Na v 1.2 and Na v 1.3. A statistical evaluation of the pairs CGTX-II and ␦-AITX-Bcg1a suggested that the data of the three isoforms Na v 1.5, Na v 1.6 and Na v 1.1 were different at level of p < 0.05. On the other hand, the other isoforms were much less affected and the effects did not appear significantly different.
To complete the picture, the fractional effects produced on the A ss component are included as insets to the appropriate plots. By comparing these data, it is evident that the two toxins here investigated produced a large A ss increase only in the isoforms Na v 1.1 and Na v 1.6. As compared to similar A ss data, but for ATX-II, AFT-II and BcIII, present in Oliveira et al. [23] , it is evident the toxins investigated in the present report show potencies (in the 100-500 nM range), which were similar to those shown by the other peptides.
3D models and molecular surfaces
As shown in Fig. 5 , the three toxins investigated were modeled and structurally represented, in order to get some clues about the role of some amino acids and their surfaces charges in their activities. The three models were validated and yielded values as expected, based on the template. The QMEAN scores for CGTX-II, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b were 0.7, 0.71 and 0.74, respectively. Panel A shows the cartoon representation of each peptide, and panel B shows the molecular surfaces of the corresponding molecules in the same orientation of panel A. Also, R 14 located in the flexible loop comprised from residues D 9 -S 19 is depicted as blue spheres in panel A, as well as other negatively charged D residues colored as red.
It can be clearly seen in panel B that the overall charged molecular surface of CGTX-II is different than those ␦-AITX-Bcg1a and ␦-AITX-Bcg1b peptides. In that orientation, CGTX-II is more positive than ␦-AITX-Bcg1a, which in turn is less negative than ␦-AITXBcg1b. For ␦-AITX-Bcg1a and ␦-AITX-Bcg1b, the occurrence of D 37 possibly contributes to the formation of a continuum of a negative patch that extends along the surface of the molecules. Especially in case of ␦-AITX-Bcg1b which also presents the D 16 amino acid (its single substitution compared to ␦-AITX-Bcg1a), showing in this case its role in the formation of the dense overall negative charge of ␦-AITX-Bcg1b. Considering the occurrence of an Asn in the 16th position in ␦-AITX-Bcg1a, this negative patch is not as intense as in the case of ␦-AITX-Bcg1b. Thus, due to this difference we may speculate that its potency may be expected to be similar to that of CGTX-II.
Discussion
Initially we should emphasize that both ␦-AITX-Bcg1a and ␦-AITX-Bcg1b toxins had their primary sequences fully determined in this work, then making possible to explore their molecular aspects more in detail. As observed in Fig. 1 , the selectivity of the CGTX-II, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b toxins is highest for Na v 1.5 followed by 1.6 and 1.1 (Nav1.5 > 1.6 > 1.1). ␦-AITX-Bcg1b was not shown to be potent and was consequently abandoned in our investigation. It is important to remind that ␦-AITX-Bcg1b presents the single N 16 D substitution in relation to its isoform ␦-AITX-Bcg1a (see Table 1 ). The latter shows a much higher potency among the assayed channels. However, CGTX-II also presents a D 16 amino acid (see Table 1 ), but its potency and selectivity are close to the observed for ␦-AITXBcg1a. In that case, it is clear that the N 16 amino acid alone should not be considered as a key determinant of the potency or activity of sea anemone peptides.
In the work by Oliveira et al. [23] , the selectivity of ATX-II (see its primary sequence in Table 1 on Na v 1.5-1.1 > 1.4-1.6 > 1.2-1.3. More recently, these three peptides were assayed in Na v 1.7 and all of them showed a smaller potency in that channel [34] , such as for CGTX-II, ␦-AITX-Bcg1a and ␦-AITX-Bcg1b here presented. The compilation of those data, together with a summary of the dose-response curves in the present study, is shown in Fig. 4 . Contrary to AFT-II and BcIII, none of the toxins employed in this study showed some preference for binding to Nav1.4. Thus, it is clear that the selectivity of sea anemone type 1 toxins is variable, and consequently the surface of contact of each peptide should vary as well.
Other authors tried to investigate this aspect [22] . They did a full alanine scanning of ATX-II (Av2) toxin, and found that some residues important for activity coincide, but many do not overlap with the contact surface of the structurally related peptide ApB [5, 10, 31] . On the other hand, although differing only by N 16 D substitution, previous studies demonstrated that BgII (Asn) is much more potent than BgIII (Asp) (see Table 1 ) [6, 28] . Consequently, this confirms that the role of each individual amino acid must be carefully examined for each toxin, and a single amino acid residue might not be as critical for binding on one isoform as for other.
Very interestingly, our present data show that all the three toxins tested do not have a high preference for binding on Nav1.2 (the preferential target of ATX-II, one of the most potent sea anemone toxins). However, the supposed binding site (site 3) [8] of these type 1 sea anemone toxins in Nav1.1 is identical [23, 30] . So, if only this region in sodium channels is interacting with sea anemone toxins, it is expected that any peptide which bind in Nav1.1 should have similar profiles of activity and affinity in Nav1.2. However, our present data show a distinct evidence (see Figs. 1-3 and Table 2 ). As observed, both CGTX-II and ␦-AITX-Bcg1a induce different effects on Nav1.1 and 1.2.
On Nav1.1 and 1.6, the peptides indeed shifted the Boltzmann inactivation curves to more depolarized potentials and maintain a pedestal (see Fig. 2 ), by the induction of a persistent current (steadystate current -A ss ), in contrary to that observed for the other clones investigated and also reports by other authors [27, 28] . This characterizes a population of bound channels that do not inactivate. In Nav1.2, the observed effects are distinct: CGTX-II causes some slight shift in the Boltzmann curves for either activation and deactivation toward more negative potentials, while ␦-AITX-Bcg1a do not alter these values. This effect may be due to the occurrence of a persistent current (A ss ), which in turn strongly modify the so called "window current" that is known to be able to alter the neuronal resting potential and shift activation to more hyperpolarized potential. In addition, the increase in the persistent currents by both peptides is negligible, in comparison to Nav1.1. This clearly suggests that the binding site of type 1 toxins is not restricted only to the supposed site 3, between segments S3 and S4 of domain IV, in agreement with previous results [23] . Also, a similar discrete shift of activation toward more hyperpolarized potentials was only observed in the toxin ApC when tested in rat DRG neurons [27] , suggesting that these sea anemone type 1 toxins might act in some way as a ␤-scorpion fashion, facilitating depolarization of affected cells. Thus, further site-directed mutagenesis studies in other regions of Navs should be performed in order to determine the other contact regions between channel and sea anemone toxins, as obviously other topological areas of such channels are involved in these interactions. Moreover, these biophysical parameters also reinforce the suggestion of dissimilar contact surfaces of each toxin among different sodium channel isoforms.
In terms of the charge distribution of the peptides and the role of positively charged amino acids, similar controversial results were found. As for ATX-II, a Lys at position 35 was described to be crucial for activity on rat Nav1.2 [25] , while for the same molecule that amino acid was not demonstrated either to alter its binding properties on neuronal cockroach membranes or decrease activity of human Nav1.5 expressed in Xenopus laevis oocytes [22] . In ApB case, a Lys in the same position was demonstrated to be determinant for its potency and activity, either in K 37 A or K 37 D substitutions [5] . Especially in the ApB-K 37 D mutant, its potency was drastically affected. Observing Table 1 , we can see that ␦-AITX-Bcg1a has a negative amino acid residue in its 38th position, where the above mentioned positively charged residues were supposed to be critical.
On the other hand, CgNa is a toxin isolated from Condylactis gigantea species and presents a dense negative charge around residues 35-37 (see Table 1 ). In spite of the presence of such a negative charge its potency is in a similar range such as BgII when tested in dorsal root ganglia (DRG) neurons [28, 29, 32] . Also, the determination of CgNa three-dimensional structure by NMR exhibits a large negative patch exposed, and a minor distribution of hydrophobic residues that are important for activity in ApB and ATX-II [29] . As pointed by the authors, this may explain that at least for CgNa the presence of positively charged amino acids and a hydrophobic patch may not be of utmost importance for its binding on sodium channels, but might contribute to a smaller potency compared to ATX-II and ApB, for instance.
Observing the modeled structures shown in Fig. 5 , we clearly see that for ␦-AITX-Bcg1a peptide an overall charge distribution similar to CgNa may occur. In its primary sequence, we observe a negatively charged amino acid (D 37 ) that is positioned in a correspondent region of D 36 and E 37 in CgNa, and their contact surface on sodium channels may also be similar. Comparing among the charged molecular surfaces of the three toxins, ␦-AITX-Bcg1a has a more intense negatively charged surface when compared to CGTX-II. As for ␦-AITX-Bcg1b, the occurrence of an Asp at position 16 may disrupt this possible surface of contact, by increasing the extent of the negative patch and make ␦-AITX-Bcg1b much less prone to affect VGSC, as shown in Fig. 1 . This is especially interesting as we consider the only N 16 D substitution observed between ␦-AITXBcg1a and ␦-AITX-Bcg1b, but the molecular surface of the latter shows that the occurrence of Asp 16 drastically increases the negatively charged surface among all three peptides. Consequently, we may suggest that the large negative surface observed in ␦-AITXBcg1b may be responsible for its mild effects among the assayed Na v s.
Conclusions
In summary, our results contribute to a better understanding of the selectivity of some sea anemone toxins toward channels Nav1.1-1.7. The presented data demonstrate that the binding sites of these toxins is not restricted to the supposed site 3, between segments S3 and S4 of domain IV.
Also, we show that previously assumed critical amino acid positions in this group of peptides may vary and should be carefully considered. By doing this we may avoid misleading interpretations by common generalizations that may arise from site-directed mutagenesis studies. Moreover, subtle variations in primary sequences of toxins may lead to drastic changes in surface charges, such as in the case of ␦-AITX-Bcg1a and ␦-AITX-Bcg1b, which may contribute to a better understanding of their contact surfaces on the targeted channels.
